1. 244 Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): results from a proof-of-concept phase II trial. (12th April 2019) Authors: Yuzaiful, Md; Yusof, Md; Wittmann, Miriam; Fernandez, Catherine; Wilson, Duncan; Edward, Sara; Abignano, Giuseppina; Alase, Adewonuola; Sharples, Linda; Laws, Philip; Goodfield, Mark; Vital, Edward M; Emery, Paul Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 47 Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): results from a proof-of-concept phase II trial. (April 2019) Authors: Md Yusof, Md Yuzaiful; Wittmann, Miriam; Fernandez, Catherine; Wilson, Duncan; Edward, Sara; Abignano, Giuseppina; Alase, Adewonuola; Laws, Philip; Goodfield, Mark; Emery, Paul; Vital, Edward Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 71 Prediction of response to rituximab in SLE using a validated two-score system for interferon status. (April 2019) Authors: Alase, Adewonuola; Wigston, Zoe; Burska, Agata; Hensor, Elizabeth; Psarras, Antonios; Md Yusof, Md Yuzaiful; Reynolds, John; Wittmann, Miriam; Bruce, Ian N; Vital, Edward Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus. Issue 5 (3rd April 2020) Authors: El‐Sherbiny, Yasser M.; Md Yusof, Md Yuzaiful; Psarras, Antonios; Hensor, Elizabeth M. A.; Kabba, Kumba Z.; Dutton, Katherine; Mohamed, Alaa A. A.; Elewaut, Dirk; McGonagle, Dennis; Tooze, Reuben; Doody, Gina; Wittmann, Miriam; Emery, Paul; Vital, Edward M. Journal: Arthritis & rheumatology Issue: Volume 72:Issue 5(2020) Page Start: 769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Brief Report: Responses to Rituximab Suggest B Cell–Independent Inflammation in Cutaneous Systemic Lupus Erythematosus. Issue 6 (June 2015) Authors: Vital, Edward M.; Wittmann, Miriam; Edward, Sara; Md Yusof, Md Yuzaiful; MacIver, Helen; Pease, Colin T.; Goodfield, M.; Emery, Paul Journal: Arthritis & rheumatology Issue: Volume 67:Issue 6(2015) Page Start: 1586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial. Issue 2 (23rd February 2022) Authors: Smith, Isabelle L; Gilberts, Rachael; Brown, Sarah; Fernandez, Catherine; Nixon, Jane; Reynolds, Catherine; Smith, Catherine; Lear, John T; Sunderland, Lesley; Green, Cathy; Goodfield, Mark; Cowdell, Fiona; Hampton, Philip; Barker, Amy; Vargas-Palacios, Armando; Tubeuf, Sandy; Wittmann, Miriam Journal: BMJ open Issue: Volume 12:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cytokines in cutaneous lupus erythematosus. (August 2011) Authors: Wittmann, Miriam; Goodfield, Mark Journal: Expert review of dermatology Issue: Volume 6:Number 4(2011) Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evidence for a regulatory loop between IFN‐γ and IL‐33 in skin inflammation. Issue 2 (31st January 2013) Authors: Seltmann, Jenny; Werfel, Thomas; Wittmann, Miriam Journal: Experimental dermatology Issue: Volume 22:Issue 2(2013:Feb.) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0179 PREDICTION OF RESPONSE TO RITUXIMAB IN SLE USING A VALIDATED TWO-SCORE SYSTEM FOR INTERFERON. (June 2019) Authors: Alase, Adewonuola; Wigston, Zoe; Burska, Agata; Hensor, Elizabeth; Yusof, Yuzaiful; Reynolds, John; Wittmann, Miriam; Bruce, Ian N.; Vital, Edward Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0429 NON TOPICAL PHARMACOLOGICAL TREATMENT OF EARLY, UNTREATED (DMARD-NAïVE, SYSTEMIC THERAPY-NäIVE) PSORIATIC DISEASE: A SYSTEMATIC REVIEW. (June 2019) Authors: Marco, Gabriele De; Berekméri, Anna; Coates, Laura C.; Dubash, Sayam; Gladman, Dafna D.; Lubrano, Ennio; Mcgonagle, Dennis; Mahmood, Farrouq; Marchesoni, Antonio; Ogdie, Alexis; Wittmann, Miriam; Marzo-Ortega, Helena; Helliwell, Philip Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗